Underweight adults have higher rates of respiratory death than the normal weight but it is unclear whether this association is causal or reflects illness-induced weight loss (reverse causality). Evidence from a 45-year follow-up of underweight participants for respiratory mortality in the Whitehall study (N=18 823; 2139 respiratory deaths) suggests that excess risk among the underweight is attributable to reverse causality. The age-adjusted and smoking-adjusted risk was 1.55-fold (95% CI 1.32 to 1.83) higher among underweight compared with normal weight participants, but attenuated in a stepwise manner to 1.14 (95% CI 0.76 to 1.71) after serial exclusions of deaths during the first 5–35 years of follow-up (Ptrend<0.001).
- COPD epidemiology
This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
Statistics from Altmetric.com
Underweight individuals appear to have an increased risk of dying from chronic respiratory disease.1–3 In the Prospective Cohort Studies Collaboration of 900 000 adults, for example, each 5-unit decrease in body mass index from 25 to 15 kg/m2 was associated with a 1.7-fold increase in respiratory mortality.1 This excess risk was evident in men and women and across adult age groups; other studies have reported similar findings.1–3
The clinical importance of these findings has been the subject of debate because it is unclear whether the association is causal or a consequence of illness-induced weight loss prior to study baseline (reverse causality). If the first interpretation were true, physicians might encourage their patients to maintain normal weight as a means of preventing respiratory disease.4 In the latter scenario, respiratory diseases such as COPD develop over many years and weight loss may precede diagnosis. In addition, some risk factors for respiratory disease, such as smoking, are also associated with weight loss, and may therefore be a further source of reverse causation bias.
The likelihood that death is caused by an existing weight-modifying condition is highest in the earliest stages of follow-up and progressively diminishes over time. Accordingly, if the strength of the underweight–mortality association attenuates when deaths occurring in earlier years of follow-up are removed from the analyses, reverse causation is a likely explanation. In the present study, we examined this issue by comparing the risk of respiratory death among underweight versus normal weight adults over an exceptionally long follow-up period of 45 years.
Data are drawn from the original Whitehall cohort study of 19 019 male London-based government employees, aged 40–69 years at study baseline in 1967–1970 (for details, see online supplementary appendix).5 Mortality surveillance was available up to 30 September 2012, allowing us to undertake analyses excluding participants who had a respiratory death in the first 5–35 years of follow-up. To examine whether these exclusions cause spurious attenuations, we repeated the analyses focusing on the association between underweight and coronary heart disease (CHD) deaths; if our approach is valid then the association should not be affected because weight loss is less likely to occur in the years prior to CHD.
During 507 648 person-years at risk, 2139 participants died from respiratory disease. Figure 1 shows that the age-adjusted and smoking-adjusted excess risk at baseline was 1.55-fold (95% CI 1.32 to 1.83) higher among underweight compared with normal weight participants (figure 1A). This HR attenuated in a stepwise manner to 1.14 (95% CI 0.76 to 1.71) after serial exclusions of deaths during the first 5–35 years of follow-up (Ptrend<0.001). Results from stratified analyses for current smokers and non-smokers revealed the same pattern of associations (figure 1B). In contrast, analyses of CHD deaths (N=4461) showed 15% lower risk among underweight relative to normal weight participants (HR=0.85, 95% CI 0.71 to 0.99), which remained unchanged after excluding participants who died during the first 35 years of follow-up (figure 1C). Detailed results can be found in the online supplementary appendix.
Exclusions of data are, in effect, subgroup analyses, raising the question whether findings could be an artefact of random variability resulting from reduced sample size or bias due to the exclusions themselves. The consistent stepwise attenuation of the HR for underweight at each additional 5-year exclusion in our data, both in the total population and in smokers and non-smokers, suggests that random variability is an unlikely explanation for our findings. Furthermore, the expected unchanged HRs for the association between underweight and CHD show that exclusions themselves do not bias effect estimates towards the null.
Taken together, evidence from the longest follow-up to date suggests that the observed association between underweight and elevated respiratory mortality is mainly attributable to reverse causation, such that underweight is a consequence and not a cause of respiratory disease or its risk factors. The Prospective Studies Collaboration, the largest study on this issue to date, excluded participants who died within the first 15 years of follow-up1 while other studies typically exclude mortality within the first 3 or 5 years. Our findings suggest that these exclusion periods are too short, as the confounded effect of underweight persists much longer.⇓
Review history and Supplementary material
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
- Data supplement 1 - Online supplement
Contributors MK drafted the first version and MJS performed statistical analyses. MK, MJS, JAB, EJB, GDB and AS-M jointly designed the hypothesis, interpreted the data and contributed to the writing of the paper. MK and MJS are guarantors.
Funding MK is supported by the Medical Research Council (MR/K013351), the National Institute of Aging (NIA) (R01AG034454), NordForsk, the Nordic Programme on Health and Welfare and an ESRC professorial fellowship (ES/J023299). MJS and EJB are supported by the British Heart Foundation (RG13/2/30098). JAB is supported by an Economic and Social Research Council (ESRC) studentship. AS-M receives research support from the US NIH NIA (R01AG013196; R01AG034454). The original screening of the Whitehall study was funded by the Department of Health and Social Security and the Tobacco Research Council.
Competing interests None declared.
Patient consent Obtained.
Ethics approval The ethics committee of the London School of Hygiene and Tropical Medicine.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.